NCT00639405

Brief Summary

The purpose of this study is to design a method to better localize parathyroid adenomas. This study will include approximately 6 patients who have not had surgery and another 25 patients who have already had surgery over the course of one year.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2005

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2005

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2008

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 20, 2008

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
Last Updated

April 27, 2011

Status Verified

October 1, 2008

Enrollment Period

2.9 years

First QC Date

March 12, 2008

Last Update Submit

April 26, 2011

Conditions

Parathyroid NeoplasmParathyroid Diseases

Keywords

ParathyroidMRISPECT

Study Arms (1)

1

subjects who are diagnosed with parathyroid adenomas. There will be 6 subjects who have not had surgery and 25 subjects who have had surgery.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects will be recruited from the Health Care Clinic

You may qualify if:

  • Subjects who are 18 years and over
  • subjects who have had a failed parathyroidectomy and now presents with persistent hyperparathyroidism or recurrent hyperparathyroidism
  • control patients with parathyroid adenomas who have not yet had surgery will be selected to test the efficacy of the software.

You may not qualify if:

  • Potential female subjects who are pregnant
  • Any potential subject who has an implanted metallic device, stent or staples
  • any subject weighing 300lb

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SUNY Upstate Medical University

Syracuse, New York, 13210, United States

Location

MeSH Terms

Conditions

Parathyroid NeoplasmsParathyroid Diseases

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System Diseases

Study Officials

  • Michele Lisi, MD

    State University of New York - Upstate Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 12, 2008

First Posted

March 20, 2008

Study Start

September 1, 2005

Primary Completion

August 1, 2008

Study Completion

August 1, 2008

Last Updated

April 27, 2011

Record last verified: 2008-10

Locations

US(1)